Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

The study, published earlier this year in the Proceedings of the National Academy of Sciences, examined how abnormal cells ...

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

For decades, gynecologic cancer treatment has used aggressive surgical intervention and chemotherapy. These methods often ...

Jay Harris, who has anchored for SportsCenter for over 10 years has shared he has been diagnosed with prostate cancer and ...

The trial evaluated the combination of GSK’s Jemperli and Zejula as a first-line therapy for stage III and IV epithelial OC.

This week’s loving giving local donation goes to an organization that helps women and men in the fight against cancer. It all started with Paula’s story and now it’s ...

Cancer can manifest in various ways, and early detection is crucial for effective treatment. As per the American Cancer ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Investing.com -- Genmab (NASDAQ: GMAB) has unveiled new data for its cancer drug Rina-S, which is being tested for use in endometrial cancer. This follows promising early results from trials in ...

Teddi Mellencamp confirmed she’s in a new relationship amid her journey with cancer. Despite the public attention they’ve ...

The updated data showed positive results and supports the company’s aim to start a Phase 111 trial later this year.